Related Experiment Videos
BCL-2 stimulates Apoptin-induced apoptosis.
A A Danen-Van Oorschot1, A J van der Eb, M H Noteborn
1Department of Molecular Cell Biology, Leiden University Medical Center, The Netherlands.
Advances in Experimental Medicine and Biology
|September 29, 1999
Summary
Apoptin, an avian virus protein, selectively triggers cancer cell death (apoptosis) independently of p53 and is enhanced by Bcl-2. It shows promise as a safe and effective anti-tumor therapy agent.
Area of Science:
- Oncology
- Molecular Biology
- Virology
Background:
- Apoptin, derived from an avian virus, induces apoptosis in tumor cells.
- The proto-oncogene Bcl-2 typically inhibits apoptosis but unexpectedly accelerates Apoptin-induced cell death in tumor cells.
- Apoptin's mechanism differs from p53-dependent apoptosis pathways.
Purpose of the Study:
- To investigate Apoptin's mechanism of action in inducing apoptosis in tumor cells.
- To explore the role of Bcl-2 in Apoptin-mediated apoptosis.
- To evaluate Apoptin's therapeutic potential as an anti-tumor agent.
Main Methods:
- Culturing various human tumorigenic and non-transformed cell lines.
- Utilizing Apoptin and overexpressing Bcl-2 in cell models.
- Conducting cellular localization studies (cytoplasmic vs. nuclear).
- Assessing anti-tumor efficacy in animal models.
Main Results:
- Apoptin induced p53-independent apoptosis in tumor cells (leukemia, lymphoma, EBV-transformed B cells).
- Bcl-2 overexpression accelerated Apoptin-induced apoptosis in tumor cells, but not in normal cells.
- Apoptin localized to the nucleus in tumor cells and the cytoplasm in normal cells.
- Apoptin demonstrated safety and efficiency as an anti-tumor agent in animal models.
Conclusions:
- Apoptin selectively targets tumor cells for apoptosis, independent of p53.
- Bcl-2 specifically enhances Apoptin's pro-apoptotic function in tumor cells.
- Apoptin's tumor-specific activity and safety profile suggest its potential as a novel anti-cancer therapeutic.